WHO Vision 2020: Have We Done It?

References

• The International Agency for the Prevention of Blindness. VISION 2020. (2020).
   Google Scholar
• Assi L, Rosman L, Chamseddine F, et al. Eye health and quality of life: an umbrella review protocol. BMJ Open. 2020;10(8):e037648. doi:10.1136/bmjopen-2020-037648.
   PubMed Web of Science ®Google Scholar
• Thylefors B. A global initiative for the elimination of avoidable blindness. Community Eye Heal. 1998;11:1–3.
   PubMedGoogle Scholar
• Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ. 1995;73:115–121.
   PubMed Web of Science ®Google Scholar
• Pizzarello L, Abiose A, Ffytche T, et al. VISION 2020: the right to sight - A global initiative to eliminate avoidable blindness. Arch Ophthalmol. 2004;122(4):615–620. doi:10.1001/archopht.122.4.615.
   PubMed Web of Science ®Google Scholar
• Frick KD, Foster A. The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am J Ophthalmol. 2003;135(4):471–476. doi:10.1016/S0002-9394(02)02110-4.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Initiative for the Elimination of Avoidable Blindness. World Health Organization; 2000.
   Google Scholar
• Bourne R, Steinmetz JD, Flaxman S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Heal. 2021;9(2):e130–e143. doi:10.1016/S2214-109X(20)30425-3.
   PubMed Web of Science ®Google Scholar
• Foster A. Vision 2020: the cataract challenge. J Community Eye Heal. 2000;13:17–19.
   PubMedGoogle Scholar
• Foster A. Cataract and ‘Vision 2020 - The right to sight’ initiative. Br J Ophthalmol. 2001;85(6):635–637. doi:10.1136/bjo.85.6.635.
   PubMed Web of Science ®Google Scholar
• Allen D, Vasavada A. Cataract and surgery for cataract. Bmj. 2006;333(7559):128–132. doi:10.1136/bmj.333.7559.128.
   PubMedGoogle Scholar
• Ramke J, Gilbert CE, Lee AC, Ackland P, Limburg H, Foster A. Effective cataract surgical coverage: an indicator for measuring quality-of-care in the context of universal health coverage. PLoS One. 2017;12,(3):e0172342. doi:10.1371/journal.pone.0172342.
   PubMed Web of Science ®Google Scholar
• Wang W, Yan W, Fotis K, et al. Cataract surgical rate and socioeconomics: a global study. Investig Ophthalmol Vis Sci. 2016;57(14):5872–5881. doi:10.1167/iovs.16-19894.
   PubMed Web of Science ®Google Scholar
• Lou L, Wang J, Xu P, Ye X, Ye J. Socioeconomic disparity in global burden of cataract: an analysis for 2013 with time trends since 1990. Am J Ophthalmol. 2017;180:91–96. doi:10.1016/j.ajo.2017.04.008.
   PubMed Web of Science ®Google Scholar
• Lewallen S, Schmidt E, Jolley E, et al. Factors affecting cataract surgical coverage and outcomes: a retrospective cross-sectional study of eye health systems in sub-Saharan Africa. BMC Ophthalmology. 2015;1:1–8.
   Google Scholar
• The International Agency for the Prevention of Blindness. National indicators. https://www.iapb.org/learn/vision-atlas/solutions/national-indicators/ (2022).
   Google Scholar
• Yan W, Wang W, van Wijngaarden P, Mueller A, He M. Longitudinal changes in global cataract surgery rate inequality and associations with socioeconomic indices. Clin Experiment Ophthalmol. 2019;47(4):453–460. doi:10.1111/ceo.13430.
   PubMed Web of Science ®Google Scholar
• Wang W, Yan W, Müller A, He M. A global view on output and outcomes of cataract surgery with national indices of socioeconomic development. Invest Ophthalmol Vis Sci. 2017;58(9):3669–3676. doi:10.1167/iovs.17-21489.
   PubMed Web of Science ®Google Scholar
• West SK. Milestones in the fight to eliminate trachoma. Ophthalmic Physiol Opt. 2020;40(2):66–74. doi:10.1111/opo.12666.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Trachoma. https://www.who.int/news-room/fact-sheets/detail/trachoma (2022).
   Google Scholar
• Lietman TM, Pinsent A, Liu F, Deiner M, Hollingsworth TD, Porco TC. Models of trachoma transmission and their policy implications: from control to elimination. Clin Infect Dis. 2018;66(suppl_4):S275–S280. doi:10.1093/cid/ciy004.
   PubMedGoogle Scholar
• Ackland P. The accomplishments of the global initiative VISION 2020: the right to sight and the focus for the next 8 years of the campaign. Indian J Ophthalmol. 2012;60(5):380–386. doi:10.4103/0301-4738.100531.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2015. African Programme for Onchocerciasis Control. World Health Organization.
   Google Scholar
• World Health Organization. Onchocerciasis. 2019. World Health Organization.
   Google Scholar
• World Health Organization. Onchocerciasis. 2022. https://www.who.int/news-room/fact-sheets/detail/onchocerciasis Accessed 27 08 2022
   Google Scholar
• Etya’alé D. Eliminating onchocerciasis as a public health problem: the beginning of the end. British J Ophthalmol. 2002;86(8):844–846. doi:10.1136/bjo.86.8.844.
   PubMed Web of Science ®Google Scholar
• Opoku NO, Bakajika DK, Kanza EM, et al. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial. Lancet. 2018;392(10154):1207–1216. doi:10.1016/S0140-6736(17)32844-1.
   PubMed Web of Science ®Google Scholar
• Gebrezgabiher G, Mekonnen Z, Yewhalaw D, Hailu A. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa. Infect Dis Poverty. 2019;8(1):1–20. doi:10.1186/s40249-019-0567-z.
   PubMedGoogle Scholar
• Gilbert CE, Anderton L, Dandona L, Foster A. Prevalence of visual impairment in children: a review of available data. Ophthalmic Epidemiol. 1999;6(1):73–82. doi:10.1076/opep.6.1.73.1571.
   PubMedGoogle Scholar
• Gillbert C, Muhit M. Twenty years of childhood blindness: what have we learnt? Community Eye Heal J. 2008;21:46–47.
   PubMedGoogle Scholar
• Gilbert C, Lepvrier-Chomette N. Chapter 50 Worldwide causes of childhood blindness. Pediatric Retina 3rd. In: Hartnett, Mary E. Wolters Kluwer. 2020;1088.
   Google Scholar
• Gilbert C, Awan H. Blindness in children. Br Med J. 2003;327(7418):760–761. doi:10.1136/bmj.327.7418.760.
   PubMedGoogle Scholar
• Bourne RRA, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Heal. 2013;1(6):e339–e349. doi:10.1016/S2214-109X(13)70113-X.
   PubMed Web of Science ®Google Scholar
• Bourne R, Adelson J, Flaxman S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years and contribution to the global burden of disease in 2020. SSRN Electron J. 2020;9:e130–143.
   Google Scholar
• Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–1042. doi:10.1016/j.ophtha.2016.01.006.
   PubMed Web of Science ®Google Scholar
• Rao G. The achievements and lasting effects of VISION 2020. Eye News. (2020).
   Google Scholar
• Zondervan M, Walker C, Astbury N, Foster A. VISION 2020 LINKS Programme: The contribution of health partnerships to reduction in blindness worldwide. Eye News.2014;20(6):32–6.
   Google Scholar
• Astbury N, Burgess P, Foster A, Mabey D, Zondervan M.Tackling Diabetic Retinopathy Globally through the VISION 2020 LINKS Diabetic Retinopathy Network. Eye News.2017;23(5):30–4.
   Google Scholar
• United Nations. World Population Prospects 2022. (2022).
   Google Scholar
• Bourne RRA, Steinmetz JD, Saylan M, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Heal. 2021;9(2):e144–e160. doi:10.1016/S2214-109X(20)30489-7.
   PubMed Web of Science ®Google Scholar
• McCracken K, Phillips DR. Demographic and epidemiological transition. Int Encycl Geogr People, Earth, Environ Technol People, Earth, Environ Technol. 2016;12:1–8.
   Google Scholar
• Resnikoff S, Kocur I. Non-communicable eye diseases: facing the future. Community Eye Health Journal. 2014;27:41–43.
   PubMedGoogle Scholar
• Zhang Y, Jin G, Fan M, et al. Time trends and heterogeneity in the disease burden of glaucoma, 1990-2017: a global analysis. J Glob Health. 2019;9,(2). doi:10.7189/jogh.09.020436.
   Web of Science ®Google Scholar
• Xu X, Wu J, Yu X, Tang Y, Tang X, Shentu X. Regional differences in the global burden of age-related macular degeneration. BMC Public Health. 2020;20(1):410. doi:10.1186/s12889-020-8445-y.
   PubMed Web of Science ®Google Scholar
• Resnikoff S, Lansingh VC, Washburn L, et al. Estimated number of ophthalmologists worldwide (International Council of Ophthalmology update): will we meet the needs? Br J Ophthalmol. 2020;104(4):588–592. doi:10.1136/bjophthalmol-2019-314336.
   PubMed Web of Science ®Google Scholar
• Resnikoff S, Felch W, Gauthier TM, Spivey B. The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200 000 practitioners. Br J Ophthalmol. 2012;96(6):783–787. doi:10.1136/bjophthalmol-2011-301378.
   PubMed Web of Science ®Google Scholar
• Abou-Gareeb I, Lewallen S, Bassett K, Courtright P. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic Epidemiol. 2001;8(1):39–56. doi:10.1076/opep.8.1.39.1540.
   PubMedGoogle Scholar
• Doyal L, Das-Bhaumik RG. Sex, gender and blindness: a new framework for equity. BMJ Open Ophthalmol. 2018;3(1):e000135. doi:10.1136/bmjophth-2017-000135.
   PubMed Web of Science ®Google Scholar
• Ye Q, Chen Y, Yan W, et al. Female gender remains a significant barrier to access cataract surgery in South Asia: a systematic review and meta-analysis. J Ophthalmol. 2020;(2020). doi:10.1155/2020/2091462.
   Web of Science ®Google Scholar
• Lewallen S, Mousa A, Bassett K, Courtright P. Cataract surgical coverage remains lower in women. Br J Ophthalmol. 2009;93(3):295–298. doi:10.1136/bjo.2008.140301.
   PubMed Web of Science ®Google Scholar